Isolated cytochrome C oxidase deficiency

Isolated cytochrome C oxidase deficiency (also known as isolated complex IV deficiency or isolated COX deficiency) is a rare mitochondrial disorder characterized by a deficiency in the activity of cytochrome C oxidase (complex IV), the terminal enzyme of the mitochondrial respiratory chain. This enzyme is essential for cellular energy production through oxidative phosphorylation. When its function is impaired, tissues with high energy demands — particularly the brain, skeletal muscles, heart, and liver — are most severely affected. The clinical presentation of isolated cytochrome C oxidase deficiency is highly variable, ranging from severe neonatal or infantile forms to milder presentations. Common clinical features include Leigh syndrome (subacute necrotizing encephalomyelopathy), hypertrophic cardiomyopathy, hepatic failure, lactic acidosis, hypotonia, developmental delay, exercise intolerance, and progressive muscle weakness. Some patients present with fatal infantile cardioencephalomyopathy, while others may have a benign infantile mitochondrial myopathy that can improve spontaneously. The severity and specific organ involvement depend largely on the underlying genetic cause and the degree of residual enzyme activity. The condition can be caused by mutations in numerous genes, including nuclear-encoded assembly factors of complex IV (such as SURF1, SCO1, SCO2, COX10, COX15, COX20, COA5, COA6, and others) as well as mitochondrial DNA-encoded structural subunits (MT-CO1, MT-CO2, MT-CO3). Accordingly, the inheritance pattern varies — it may be autosomal recessive when caused by nuclear gene mutations or follow maternal (mitochondrial) inheritance when caused by mtDNA mutations. There is currently no cure for isolated cytochrome C oxidase deficiency. Treatment is primarily supportive and symptomatic, and may include supplementation with cofactors such as riboflavin and coenzyme Q10, management of lactic acidosis, nutritional support, physical therapy, and treatment of organ-specific complications. Prognosis varies widely depending on the specific genetic etiology and clinical severity.

Common questions about Isolated cytochrome C oxidase deficiency